Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Researchers Complete Re-creation of 1918 Virus

By Biotechdaily staff writers
Posted on 28 Oct 2005
After almost 10 years of research, scientists have completed the re-creation of the influenza virus that took the lives of 20-50 million people worldwide in 1918 and 1919.

The work was conducted by scientists from the U.S. More...
Armed Forces Institute of Pathology (Washington, DC, USA), the U.S. Centers of Disease Control and Prevention (Atlanta, GA, USA), and Mount Sinai School of Medicine (New York, NY, USA). The findings have convinced the scientists that the 1918 virus began as an avian virus.

It has been difficult to study the 1918 virus since samples were not preserved at the time of the pandemic. Dr. Jeffery Taubenberger, chief of pathology at the U.S. Armed Forces Institute of Pathology, and his team have focused on publishing sequences for the genes of the virus, using materials preserved in the Alaskan permafrost and in the lungs of U.S. solders killed by the flu. They recently finished sequencing the three genes remaining. They have discovered 10 changes in amino acids that differ from other avian viruses, which suggest the virus might have mutated on its own to become transmissible in humans. The H5N1 avian virus that has so far claimed the lives of more than 50 people in Asia has already made five of these 10 changes. The team's work was published in the October 6, 2005, issue of Nature.

The other researchers, from Mount Sinai and the CDC, have reconstructed the virus by using reverse genetics, in order to learn what made it so lethal. The virus had the ability to enter cells deep in the lungs that flu viruses usually do not reach. The researchers focused on a gene in the re-created 1918 virus that allowed the virus to attach to cells and multiply. When that gene was removed, the virus lost its virulence. Moreover, certain genetic mutations of the virus have been found in the H5N1 strain, suggesting the new strain may follow a similar route. This team's work was published in the October 7, 2005, issue of Science.

According to Terrence Tumpey, a senior scientist at the CDC, the 1918 virus would be unlikely today to cause a pandemic. It is in the same family as those viruses many people have been exposed to over recent years, either by vaccination or natural infection, and thus they have developed some immune protection.

"This groundbreaking research helps unlock the mystery of the 1918 flu pandemic and is critically important in our efforts to prepare for pandemic influenza,” said CDC director Dr. Julie Gergerding.





Related Links:
Armed Forces Institute of Pathology
CDC
Mount Sinai

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Cancer cells (red) stick to mesothelial cells (green) and form hybrid spheres that cut into surrounding abdominal tissue (Photo courtesy of Uno et al., 2026)

Abdominal Fluid Testing Can Predict Ovarian Cancer Progression

Ovarian cancer kills more women than any other gynecological cancer, largely because it is usually diagnosed only after it has spread widely within the abdomen. Unlike many other cancers, it does not rely... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.